Kodiak Sciences is higher today in the stock price.  I am not sure you recall but the company is a small cap bio tech based in Palo Alto CA that works with developing novel therapies to serve patients with Age-Related Macular Degeneration as well as Diabetic Retinopathy.  Take a peek at the company profile at the link here:  https://kodiak.com

Macular Degeneration is the leading cause of blindness in older adults.  Wet Age -Related Macular Degeneration is another important area Kodiak Sciences focuses on finding therapies for.

As baby boomers continue to age these diseases are affecting more and more people.  It is estimated that *Age Related Macular Degeneration  affects 170 million people worldwide. (* by WebMD).  With these type of numbers of persons affected a company who can come up with relief for those who suffer lack of vision or worsening of vision due to age could stand to have a profitable therapy that many could use.

Note that in my opinion and research much of the progress for any bio tech companies naturally relies upon research and development and proven effectiveness of therapies and medications before any can be approved by the FDA and brought to the market place for general use.  Small cap bio tech companies have no guarantees that the research and development will prove profitable and the stock price is actually based on the how the investors see the progress of the therapies and products a bio tech company is working upon.  In looking at the annual statement released by the company they note that the stock price feel last year due to a lack of quality result on a therapy they were working on.  

PLEASE NOTE: I do not give advice for investments and this is not a recommendation or advertisement or solicitation. This post and all posts and videos on my Real Hot Stock Tips are my opinions only and for information and entertainment purposes. Please contact your licensed investment professional before making investments and do your due diligence.